Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Adenoid Cystic × Everolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 94 Carcinoma, Renal Cell 67 Neoplasm Metastasis 41 Neoplasms 34 Neuroendocrine Tumors 31 Kidney Neoplasms 24 Recurrence 16 Prostatic Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Tuberous Sclerosis 15 Head and Neck Neoplasms 14 Triple Negative Breast Neoplasms 13 Lymphoma, Mantle-Cell 13 Lymphoma 12 Hodgkin Disease 12 Glioblastoma 12 Colorectal Neoplasms 12 Carcinoma, Hepatocellular 12 Brain Neoplasms 12 Sarcoma 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Pancreatic Neoplasms 11 Lymphoma, Large B-Cell, Diffuse 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Carcinoma, Neuroendocrine 10 Waldenstrom Macroglobulinemia 9 Stomach Neoplasms 9 Multiple Myeloma 9 Lymphoma, Follicular 9 Lung Neoplasms 9

Interventions

pembrolizumab 5 apatinib 3 Magnetic Resonance Spectroscopy 3 Imatinib Mesylate 3 Carboplatin 3 lenvatinib 2 gallium 68 PSMA-11 2 Specimen Handling 2 Nivolumab 2 Cisplatin 2 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 tislelizumab 1 regorafenib 1 enfortumab vedotin 1 cabozantinib 1 amivantamab 1 Tretinoin 1 Trastuzumab 1 Tablets 1 Surveys and Questionnaires 1 Standard of Care 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Radiation 1 Protons 1 Pemetrexed 1 Nelfinavir 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Lutetium-177 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01152840 2015-05-20

ACCRAD001

Seoul National University Hospital

Phase 2 Completed

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡